These medications work by mimicking the action of the naturally occurring GLP-1 hormone, which enhances insulin secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety
8 GLP-1 RAs and DR: What the data show The CDCs Vision and Eye Health Surveillance System estimated that in 2021, there were 9.6 million people (26 percent of those with diabetes) living with diabetic retinopathy in the United States and among them, 1.84 million people (5 percent) living with vision-threatening diabetic retinopathy
In future, it is likely that the clinical indications for GLP- 1RAs will expand, with pharmaceutical companies running various drug trials to substantiate a wider array of use cases, such as the reduction of cardiovascular risk and the treatment of chronic kidney disease
GLP-1 receptors are less expensive in many other countries (for example, a recent U.S
If your COVID-19 symptoms are mild and you can maintain adequate hydration and nutrition, continuing semaglutide is generally safe